Time for oncologists to opt in for routine opt-out HIV testing?

作者: Elizabeth Y Chiao , Bruce J Dezube , Susan E Krown , William Wachsman , Malcolm V Brock

DOI: 10.1001/JAMA.2010.752

关键词:

摘要: Human immunodeficiency virus (HIV)-infected individuals are at high risk of malignancies. However, it is not currently the standard care to routinely test cancer patients for HIV. In 2006, Centers Disease Control and Prevention recommended HIV testing in all health settings, calling nontargeted "opt-out" screening. For a variety reasons, routine opt-out still widely used United States. Although many barriers have been addressed, such continues be conducted primarily venues that target specific patient populations as pregnant women. has piloted emergency departments, less emphasis placed on other clinical settings. this article, background, rationale, evidence supporting presented. addition, discussed potential improve outcomes by facilitating appropriate management during treatment who found positive.

参考文章(47)
L. A. Valleroy, R. L. Shouse, T. Kajese, H. I. Hall, Late HIV testing - 34 states, 1996-2005. Morbidity and Mortality Weekly Report. ,vol. 58, pp. 661- 665 ,(2009)
Amanda Mocroft, Ole Kirk, Nathan Clumeck, Panaglotis Gargalianos-Kakolyris, Hanna Trocha, Nelly Chentsova, Francisco Antunes, Hans-J�rgen Stellbrink, Andrew N. Phillips, Jens D. Lundgren, The changing pattern of Kaposi sarcoma in patients with HIV, 1994-2003 Cancer. ,vol. 100, pp. 2644- 2654 ,(2004) , 10.1002/CNCR.20309
R.A. Coutinho, o.m. AMC-werkgroeplid, Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults Journal of the National Cancer Institute. ,vol. 92, pp. 1823- 1830 ,(2000)
Jean-Philippe Spano, Dominique Costagliola, Christine Katlama, Nicolas Mounier, Eric Oksenhendler, David Khayat, None, AIDS-Related Malignancies: State of the Art and Therapeutic Challenges Journal of Clinical Oncology. ,vol. 26, pp. 4834- 4842 ,(2008) , 10.1200/JCO.2008.16.8252
Mark Bower, Tom Powles, Tom Newsom-Davis, Christina Thirlwell, Justin Stebbing, Sundihya Mandalia, Mark Nelson, Brian Gazzard, HIV-associated anal cancer: has highly active antiretroviral therapy reduced the incidence or improved the outcome? Journal of Acquired Immune Deficiency Syndromes. ,vol. 37, pp. 1563- 1565 ,(2004) , 10.1097/00126334-200412150-00004
Suzanna Attia, Matthias Egger, Monika Müller, Marcel Zwahlen, Nicola Low, Sexual transmission of HIV according to viral load and antiretroviral therapy: systematic review and meta-analysis AIDS. ,vol. 23, pp. 1397- 1404 ,(2009) , 10.1097/QAD.0B013E32832B7DCA
Lawrence D Kaplan, Donald I Abrams, Ellen Feigal, Michael McGrath, James Kahn, Padraic Neville, John Ziegler, Paul A Volberding, AIDS-Associated Non-Hodgkin's Lymphoma in San Francisco JAMA: The Journal of the American Medical Association. ,vol. 261, pp. 719- 724 ,(1989) , 10.1001/JAMA.1989.03420050069041
T Powles, C Thirwell, T Newsom-Davis, M Nelson, P Shah, S Cox, B Gazzard, M Bower, Does HIV adversely influence the outcome in advanced non-small-cell lung cancer in the era of HAART? British Journal of Cancer. ,vol. 89, pp. 457- 459 ,(2003) , 10.1038/SJ.BJC.6601111
Alexandra M Levine, Management of AIDS-related lymphoma. Current Opinion in Oncology. ,vol. 20, pp. 522- 528 ,(2008) , 10.1097/CCO.0B013E3283094EC7